SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-285234
Filing Date
2023-11-29
Accepted
2023-11-29 16:47:16
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d616213d424b5.htm 424B5 510569
2 EX-FILING FEES d616213dexfilingfees.htm EX-FILING FEES 35034
3 GRAPHIC g616213g70d92.jpg GRAPHIC 71957
  Complete submission text file 0001193125-23-285234.txt   645870
Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Filer) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-267578 | Film No.: 231452976
SIC: 2834 Pharmaceutical Preparations